The Recombinant and Reconstituted Novel Albumin-Lidamycin Conjugate Shows Lasting Tumor Imaging and Intensively Enhanced Therapeutic Efficacy | |
Li, Liang; Hu, Lei; Zhao, Chun-yan; Zhang, Sheng-hua; Wang, Rong; Li, Yi; Shao, Rong-guang; Zhen, Yong-su | |
2018 | |
卷号 | 29期号:9页码:3104-3112 |
ISSN号 | 1043-1802 |
DOI | 10.1021/acs.bioconjchem.8b00456 |
URL标识 | 查看原文 |
收录类别 | SCIE ; PUBMED |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6355480 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Li, Liang,Hu, Lei,Zhao, Chun-yan,et al. The Recombinant and Reconstituted Novel Albumin-Lidamycin Conjugate Shows Lasting Tumor Imaging and Intensively Enhanced Therapeutic Efficacy[J],2018,29(9):3104-3112. |
APA | Li, Liang.,Hu, Lei.,Zhao, Chun-yan.,Zhang, Sheng-hua.,Wang, Rong.,...&Zhen, Yong-su.(2018).The Recombinant and Reconstituted Novel Albumin-Lidamycin Conjugate Shows Lasting Tumor Imaging and Intensively Enhanced Therapeutic Efficacy.,29(9),3104-3112. |
MLA | Li, Liang,et al."The Recombinant and Reconstituted Novel Albumin-Lidamycin Conjugate Shows Lasting Tumor Imaging and Intensively Enhanced Therapeutic Efficacy".29.9(2018):3104-3112. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论